United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 250 mg - symptomatic  trichomoniasis. metronidazole tablets, usp are indicated for the treatment of t.  vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). asymptomatic  trichomoniasis. metronidazole tablets, usp are indicated in the treatment of asymptomatic t.  vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. treatment  of  asymptomatic  sexual  partners.  t.  vaginalis infection is a venereal disease. therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. the decision as to whether to treat an asymptomatic

United States - English - NLM (National Library of Medicine)

cadila healthcare limited - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 250 mg - symptomatic  trichomoniasis. metronidazole tablets, usp are indicated for the treatment of t.  vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). asymptomatic  trichomoniasis. metronidazole tablets, usp are indicated in the treatment of asymptomatic t.  vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. treatment  of  asymptomatic  sexual  partners.  t.  vaginalis infection is a venereal disease. therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. the decision as to whether to treat an asymptomatic

United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 250 mg - symptomatic trichomoniasis. metronidazole, usp is indicated for the treatment of t. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). asymptomatic trichomoniasis. metronidazole, usp is indicated in the treatment of asymptomatic t. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. treatment of asymptomatic sexual partners. t. vaginalis infection is a venereal disease. therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. the decision as to whether to treat an asymptomatic male partner who has a negat

United States - English - NLM (National Library of Medicine)

hospira, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - treatment of anaerobic infections metronidazole injection, usp is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. indicated surgical procedures should be performed in conjunction with metronidazole therapy. in a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to metronidazole. metronidazole is effective in bacteroides fragilis infections resistant to clindamycin, chloramphenicol and penicillin. intra-abdominal infections , including peritonitis, intra-abdominal abscess and liver abscess, caused by bacteroides species including the b. fragilis group (b. fragilis, b. distasonis, b. ovatus,  b. thetaiotaomicron, b. vulgatus ).  clostridium species, eubacterium species, peptococcus species, and peptostreptococcus species. skin and skin structure infections caused by bacteroides species including b. fragilis group, clostridium species, peptococcus species, peptos

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - treatment of anaerobic infections metronidazole injection, usp is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. indicated surgical procedures should be performed in conjunction with metronidazole therapy. in a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to metronidazole. metronidazole is effective in bacteroides fragilis  infections resistant to clindamycin, chloramphenicol and penicillin. intra-abdominal infections , including peritonitis, intra-abdominal abscess and liver abscess, caused by  bacteroides  species including the  b. fragilis  group ( b. fragilis, b. distasonis, b. ovatus, b. thetaiotaomicron, b. vulgatus ).  clostridium  species,  eubacterium  species,  peptococcus  species, and  peptostreptococcus  species. skin and skin structure infections  caused by  bacteroides  species including  b. fragilis  group,  clostridium  species,  peptococcus  species,  peptostre

United States - English - NLM (National Library of Medicine)

henry schein, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - treatment of anaerobic infections metronidazole injection, usp is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. indicated surgical procedures should be performed in conjunction with metronidazole therapy. in a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to metronidazole. metronidazole is effective in bacteroides fragilis  infections resistant to clindamycin, chloramphenicol and penicillin. intra-abdominal infections , including peritonitis, intra-abdominal abscess and liver abscess, caused by  bacteroides  species including the  b. fragilis  group ( b. fragilis, b. distasonis, b. ovatus, b. thetaiotaomicron, b. vulgatus ).  clostridium  species,  eubacterium  species,  peptococcus  species, and  peptostreptococcus  species. skin and skin structure infections  caused by  bacteroides  species including  b. fragilis  group,  clostridium  species,  peptococcus  species,  peptostre

Canada - English - Health Canada

mint pharmaceuticals inc - metronidazole - tablet - 250mg - metronidazole 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - metronidazole -

Canada - English - Health Canada

baxter corporation - metronidazole - solution - 5mg - metronidazole 5mg - miscellaneous antiprotozoals

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - metronidazole - cutaneous gel - 7.5mg/1gram